{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-042292","form_type":"8-K","ticker":"ANEB","cik":"0001815974","company_name":"Anebulo Pharmaceuticals, Inc.","filed_at":"2023-11-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.624349+00:00","generated_at":"2026-06-07T22:47:39.528236+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Anebulo stockholders approve increase in authorized shares and re-elect directors","bullets":["Stockholders re-elected Jason M. Aryeh and Bimal Shah as Class III directors with ~23.1M votes for each.","Ratified EisnerAmper LLP as independent auditor for fiscal 2024 (23,302,065 for, 2,075 against).","Approved amendment to increase authorized common shares from 40M to 50M (23,263,127 for).","The authorized share amendment was filed with Delaware Secretary of State on Nov 20, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-042292","json":"https://secwatch.observer/filing/0001493152-23-042292.json","markdown":"https://secwatch.observer/filing/0001493152-23-042292.md","text":"https://secwatch.observer/filing/0001493152-23-042292.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815974/000149315223042292/0001493152-23-042292-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815974/000149315223042292/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T22:47:39.528236+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"276db8bb4c826c1ebf8d19f1d2d4595be645eac4","claim":"Anebulo Pharmaceuticals, Inc. shareholders approved Approval of an amendment to our Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 40,000,000 to 50,000,000. at the 2023-11-20 meeting.","evidence_excerpt":"Proposal No. 3 – Approval of an amendment to our Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 40,000,000 to 50,000,000.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1815974/000149315223042292/0001493152-23-042292-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-20"}],"fact_type":"shareholder_vote"},{"claim_id":"63959b51ef70229bd716f2809a463cba309b7dce","claim":"Anebulo Pharmaceuticals, Inc. shareholders approved Ratification of the selection by the Audit Committee of the Board of Directors of EisnerAmper LLP as the independent registered public accounting firm of the Company for its fiscal year ending June 30, 2024. at the 2023-11-20 meeting.","evidence_excerpt":"Proposal No. 2 – Ratification of the selection by the Audit Committee of the Board of Directors of EisnerAmper LLP as the independent registered public accounting firm of the Company for its fiscal year ending June 30, 2024.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1815974/000149315223042292/0001493152-23-042292-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-20"}],"fact_type":"shareholder_vote"},{"claim_id":"ae6be1e3af6b51d8519fc118f93d409e82df3325","claim":"Anebulo Pharmaceuticals, Inc. shareholders approved Election of Directors at the 2023-11-20 meeting.","evidence_excerpt":"Proposal No. 1 - Election of Directors The stockholders elected the following two individuals to the Board of Directors to hold office until the 2026 Annual Meeting of Stockholders as Class III directors.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1815974/000149315223042292/0001493152-23-042292-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-11-20"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}